In 2022, Georgia secured $638 million from settlements with major pharmaceutical entities and an additional $13 million from McKinsey & Company to combat the opioid crisis. These Funds support strategic initiatives like expanding treatment options, increasing public awareness, and providing life-saving naloxone, overseen by the Georgia Opioid Settlement Advisory Commission.
The Georgia Opioid Crisis Abatement Trust was created to receive and administer Georgia’s share of funds from national settlements with opioid manufacturers and distributors. Funds held by the Trust will be used to support drug addiction prevention, treatment and recovery services.
"Like every other state, the opioid crisis has hit Georgia communities and families hard and with lasting effect. These funds will help us fight the good fight against the disease of addiction, help us make our communities more secure, and help us see that justice is done for the victims of these opioid manufacturers and distributors.”
